Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

Inflammatory Factor Receptor Toll‐like Receptor 4 Controls Telomeres Through Heterochromatin Protein 1 Isoforms in Liver Cancer Stem Cell

Toll-like Receptor 4 Signaling Promotes Invasion of Hepatocellular Carcinoma Cells Through MKK4/JNK Pathway.

TLR4 Signaling Promotes Immune Escape of Human Lung Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance.

KLF4 Downregulates Htert Expression and Telomerase Activity to Inhibit Lung Carcinoma Growth.

TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.

TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells.

Toll Like Receptor 4 Facilitates Invasion and Migration As A Cancer Stem Cell Marker in Hepatocellular Carcinoma

Toll-like Receptor 4 Signaling Promotes Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Induced by Lipopolysaccharide

Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Cancer Cells Promotes Cell Survival and Proliferation in Hepatocellular Carcinoma

TR4 Nuclear Receptor Enhances the Cisplatin Chemo-Sensitivity Via Altering the ATF3 Expression to Better Suppress HCC Cell Growth

TR4 Nuclear Receptor Suppresses HCC Cell Invasion Via Downregulating the EphA2 Expression

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC

Toll-like Receptor-4 is a Target for Suppression of Proliferation and Chemoresistance in HepG2 Hepatoblastoma Cells.

Noncoding Telomeric Repeat‐containing RNA Inhibits the Progression of Hepatocellular Carcinoma by Regulating Telomerase‐mediated Telomere Length

Downregulation of Toll-Like Receptor 4 Induces Suppressive Effects on Hepatitis B Virus-Related Hepatocellular Carcinoma Via ERK1/2 Signaling

LIN28 and histone H3K4 methylase induce TLR4 to generate tumor-initiating stem-like cells

Tumorigenicity of Cancer Stem-Like Cells Derived from Hepatocarcinoma is Regulated by Microrna-145.

Long Noncoding Rna Tp53tg1 Suppresses The Growth And Metastasis Of Hepatocellular Carcinoma By Regulating The Prdx4/Beta-Catenin Pathway

Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1.

Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis